High tumor mutation burden is associated with DNA damage repair gene mutation in breast carcinomas.

Our data indicate the importance of DNA damage repair proteins in maintaining DNA integrity and immune reaction and breast carcinoma patients with DDR mutation may benefit from immunotherapy.